Pharma & Healthcare
Global Gastroparesis Drugs Market Research Report 2025
- Apr 16, 25
- ID: 192777
- Pages: 87
- Figures: 80
- Views: 2
The global market for Gastroparesis Drugs was valued at US$ 6152 million in the year 2024 and is projected to reach a revised size of US$ 8227 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gastroparesis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroparesis Drugs.
The Gastroparesis Drugs market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastroparesis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroparesis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Segment by Type
Prokinetic Agents
Antiemetic Agents
Others
Segment by Application
Diabetic Gastroparesis
Idiopathic Gastroparesis
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastroparesis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastroparesis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gastroparesis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroparesis Drugs.
The Gastroparesis Drugs market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastroparesis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroparesis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Segment by Type
Prokinetic Agents
Antiemetic Agents
Others
Segment by Application
Diabetic Gastroparesis
Idiopathic Gastroparesis
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastroparesis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastroparesis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Gastroparesis Drugs Market Overview
1.1 Product Definition
1.2 Gastroparesis Drugs by Type
1.2.1 Global Gastroparesis Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Prokinetic Agents
1.2.3 Antiemetic Agents
1.2.4 Others
1.3 Gastroparesis Drugs by Application
1.3.1 Global Gastroparesis Drugs Market Value by Application (2024 VS 2031)
1.3.2 Diabetic Gastroparesis
1.3.3 Idiopathic Gastroparesis
1.4 Global Gastroparesis Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastroparesis Drugs Revenue 2020-2031
1.4.2 Global Gastroparesis Drugs Sales 2020-2031
1.4.3 Global Gastroparesis Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gastroparesis Drugs Market Competition by Manufacturers
2.1 Global Gastroparesis Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gastroparesis Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gastroparesis Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gastroparesis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastroparesis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastroparesis Drugs, Product Type & Application
2.7 Global Key Manufacturers of Gastroparesis Drugs, Date of Enter into This Industry
2.8 Global Gastroparesis Drugs Market Competitive Situation and Trends
2.8.1 Global Gastroparesis Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gastroparesis Drugs Players Market Share by Revenue
2.8.3 Global Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gastroparesis Drugs Market Scenario by Region
3.1 Global Gastroparesis Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gastroparesis Drugs Sales by Region: 2020-2031
3.2.1 Global Gastroparesis Drugs Sales by Region: 2020-2025
3.2.2 Global Gastroparesis Drugs Sales by Region: 2026-2031
3.3 Global Gastroparesis Drugs Revenue by Region: 2020-2031
3.3.1 Global Gastroparesis Drugs Revenue by Region: 2020-2025
3.3.2 Global Gastroparesis Drugs Revenue by Region: 2026-2031
3.4 North America Gastroparesis Drugs Market Facts & Figures by Country
3.4.1 North America Gastroparesis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gastroparesis Drugs Sales by Country (2020-2031)
3.4.3 North America Gastroparesis Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gastroparesis Drugs Market Facts & Figures by Country
3.5.1 Europe Gastroparesis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gastroparesis Drugs Sales by Country (2020-2031)
3.5.3 Europe Gastroparesis Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastroparesis Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Gastroparesis Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gastroparesis Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Gastroparesis Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gastroparesis Drugs Market Facts & Figures by Country
3.7.1 Latin America Gastroparesis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gastroparesis Drugs Sales by Country (2020-2031)
3.7.3 Latin America Gastroparesis Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastroparesis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastroparesis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gastroparesis Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gastroparesis Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastroparesis Drugs Sales by Type (2020-2031)
4.1.1 Global Gastroparesis Drugs Sales by Type (2020-2025)
4.1.2 Global Gastroparesis Drugs Sales by Type (2026-2031)
4.1.3 Global Gastroparesis Drugs Sales Market Share by Type (2020-2031)
4.2 Global Gastroparesis Drugs Revenue by Type (2020-2031)
4.2.1 Global Gastroparesis Drugs Revenue by Type (2020-2025)
4.2.2 Global Gastroparesis Drugs Revenue by Type (2026-2031)
4.2.3 Global Gastroparesis Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Gastroparesis Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gastroparesis Drugs Sales by Application (2020-2031)
5.1.1 Global Gastroparesis Drugs Sales by Application (2020-2025)
5.1.2 Global Gastroparesis Drugs Sales by Application (2026-2031)
5.1.3 Global Gastroparesis Drugs Sales Market Share by Application (2020-2031)
5.2 Global Gastroparesis Drugs Revenue by Application (2020-2031)
5.2.1 Global Gastroparesis Drugs Revenue by Application (2020-2025)
5.2.2 Global Gastroparesis Drugs Revenue by Application (2026-2031)
5.2.3 Global Gastroparesis Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Gastroparesis Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sumitomo
6.1.1 Sumitomo Company Information
6.1.2 Sumitomo Description and Business Overview
6.1.3 Sumitomo Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sumitomo Gastroparesis Drugs Product Portfolio
6.1.5 Sumitomo Recent Developments/Updates
6.2 Cadila Pharmaceuticals
6.2.1 Cadila Pharmaceuticals Company Information
6.2.2 Cadila Pharmaceuticals Description and Business Overview
6.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolio
6.2.5 Cadila Pharmaceuticals Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Gastroparesis Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Gastroparesis Drugs Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson & Johnson Gastroparesis Drugs Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Gastroparesis Drugs Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Kyowa Kirin Pharmaceuticals
6.7.1 Kyowa Kirin Pharmaceuticals Company Information
6.7.2 Kyowa Kirin Pharmaceuticals Description and Business Overview
6.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolio
6.7.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates
6.8 Hanmi Pharm
6.8.1 Hanmi Pharm Company Information
6.8.2 Hanmi Pharm Description and Business Overview
6.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hanmi Pharm Gastroparesis Drugs Product Portfolio
6.8.5 Hanmi Pharm Recent Developments/Updates
6.9 Ani Pharmaceuticals
6.9.1 Ani Pharmaceuticals Company Information
6.9.2 Ani Pharmaceuticals Description and Business Overview
6.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ani Pharmaceuticals Gastroparesis Drugs Product Portfolio
6.9.5 Ani Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastroparesis Drugs Industry Chain Analysis
7.2 Gastroparesis Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastroparesis Drugs Production Mode & Process Analysis
7.4 Gastroparesis Drugs Sales and Marketing
7.4.1 Gastroparesis Drugs Sales Channels
7.4.2 Gastroparesis Drugs Distributors
7.5 Gastroparesis Drugs Customer Analysis
8 Gastroparesis Drugs Market Dynamics
8.1 Gastroparesis Drugs Industry Trends
8.2 Gastroparesis Drugs Market Drivers
8.3 Gastroparesis Drugs Market Challenges
8.4 Gastroparesis Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Gastroparesis Drugs by Type
1.2.1 Global Gastroparesis Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Prokinetic Agents
1.2.3 Antiemetic Agents
1.2.4 Others
1.3 Gastroparesis Drugs by Application
1.3.1 Global Gastroparesis Drugs Market Value by Application (2024 VS 2031)
1.3.2 Diabetic Gastroparesis
1.3.3 Idiopathic Gastroparesis
1.4 Global Gastroparesis Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastroparesis Drugs Revenue 2020-2031
1.4.2 Global Gastroparesis Drugs Sales 2020-2031
1.4.3 Global Gastroparesis Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gastroparesis Drugs Market Competition by Manufacturers
2.1 Global Gastroparesis Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gastroparesis Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gastroparesis Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gastroparesis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastroparesis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastroparesis Drugs, Product Type & Application
2.7 Global Key Manufacturers of Gastroparesis Drugs, Date of Enter into This Industry
2.8 Global Gastroparesis Drugs Market Competitive Situation and Trends
2.8.1 Global Gastroparesis Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gastroparesis Drugs Players Market Share by Revenue
2.8.3 Global Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gastroparesis Drugs Market Scenario by Region
3.1 Global Gastroparesis Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gastroparesis Drugs Sales by Region: 2020-2031
3.2.1 Global Gastroparesis Drugs Sales by Region: 2020-2025
3.2.2 Global Gastroparesis Drugs Sales by Region: 2026-2031
3.3 Global Gastroparesis Drugs Revenue by Region: 2020-2031
3.3.1 Global Gastroparesis Drugs Revenue by Region: 2020-2025
3.3.2 Global Gastroparesis Drugs Revenue by Region: 2026-2031
3.4 North America Gastroparesis Drugs Market Facts & Figures by Country
3.4.1 North America Gastroparesis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gastroparesis Drugs Sales by Country (2020-2031)
3.4.3 North America Gastroparesis Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gastroparesis Drugs Market Facts & Figures by Country
3.5.1 Europe Gastroparesis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gastroparesis Drugs Sales by Country (2020-2031)
3.5.3 Europe Gastroparesis Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastroparesis Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Gastroparesis Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gastroparesis Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Gastroparesis Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gastroparesis Drugs Market Facts & Figures by Country
3.7.1 Latin America Gastroparesis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gastroparesis Drugs Sales by Country (2020-2031)
3.7.3 Latin America Gastroparesis Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastroparesis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastroparesis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gastroparesis Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gastroparesis Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastroparesis Drugs Sales by Type (2020-2031)
4.1.1 Global Gastroparesis Drugs Sales by Type (2020-2025)
4.1.2 Global Gastroparesis Drugs Sales by Type (2026-2031)
4.1.3 Global Gastroparesis Drugs Sales Market Share by Type (2020-2031)
4.2 Global Gastroparesis Drugs Revenue by Type (2020-2031)
4.2.1 Global Gastroparesis Drugs Revenue by Type (2020-2025)
4.2.2 Global Gastroparesis Drugs Revenue by Type (2026-2031)
4.2.3 Global Gastroparesis Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Gastroparesis Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gastroparesis Drugs Sales by Application (2020-2031)
5.1.1 Global Gastroparesis Drugs Sales by Application (2020-2025)
5.1.2 Global Gastroparesis Drugs Sales by Application (2026-2031)
5.1.3 Global Gastroparesis Drugs Sales Market Share by Application (2020-2031)
5.2 Global Gastroparesis Drugs Revenue by Application (2020-2031)
5.2.1 Global Gastroparesis Drugs Revenue by Application (2020-2025)
5.2.2 Global Gastroparesis Drugs Revenue by Application (2026-2031)
5.2.3 Global Gastroparesis Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Gastroparesis Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sumitomo
6.1.1 Sumitomo Company Information
6.1.2 Sumitomo Description and Business Overview
6.1.3 Sumitomo Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sumitomo Gastroparesis Drugs Product Portfolio
6.1.5 Sumitomo Recent Developments/Updates
6.2 Cadila Pharmaceuticals
6.2.1 Cadila Pharmaceuticals Company Information
6.2.2 Cadila Pharmaceuticals Description and Business Overview
6.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolio
6.2.5 Cadila Pharmaceuticals Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Gastroparesis Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Gastroparesis Drugs Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson & Johnson Gastroparesis Drugs Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Gastroparesis Drugs Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Kyowa Kirin Pharmaceuticals
6.7.1 Kyowa Kirin Pharmaceuticals Company Information
6.7.2 Kyowa Kirin Pharmaceuticals Description and Business Overview
6.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolio
6.7.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates
6.8 Hanmi Pharm
6.8.1 Hanmi Pharm Company Information
6.8.2 Hanmi Pharm Description and Business Overview
6.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hanmi Pharm Gastroparesis Drugs Product Portfolio
6.8.5 Hanmi Pharm Recent Developments/Updates
6.9 Ani Pharmaceuticals
6.9.1 Ani Pharmaceuticals Company Information
6.9.2 Ani Pharmaceuticals Description and Business Overview
6.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ani Pharmaceuticals Gastroparesis Drugs Product Portfolio
6.9.5 Ani Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastroparesis Drugs Industry Chain Analysis
7.2 Gastroparesis Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastroparesis Drugs Production Mode & Process Analysis
7.4 Gastroparesis Drugs Sales and Marketing
7.4.1 Gastroparesis Drugs Sales Channels
7.4.2 Gastroparesis Drugs Distributors
7.5 Gastroparesis Drugs Customer Analysis
8 Gastroparesis Drugs Market Dynamics
8.1 Gastroparesis Drugs Industry Trends
8.2 Gastroparesis Drugs Market Drivers
8.3 Gastroparesis Drugs Market Challenges
8.4 Gastroparesis Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Gastroparesis Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Gastroparesis Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Gastroparesis Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Gastroparesis Drugs Sales (Kg) of Key Manufacturers (2020-2025)
Table 5. Global Gastroparesis Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Gastroparesis Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Gastroparesis Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Gastroparesis Drugs Average Price (US$/mg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Gastroparesis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gastroparesis Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gastroparesis Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Gastroparesis Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gastroparesis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroparesis Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gastroparesis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Gastroparesis Drugs Sales by Region (2020-2025) & (Kg)
Table 18. Global Gastroparesis Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Gastroparesis Drugs Sales by Region (2026-2031) & (Kg)
Table 20. Global Gastroparesis Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Gastroparesis Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Gastroparesis Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Gastroparesis Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Gastroparesis Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Gastroparesis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
Table 27. North America Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
Table 28. North America Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Gastroparesis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
Table 32. Europe Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
Table 33. Europe Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Gastroparesis Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Gastroparesis Drugs Sales by Region (2020-2025) & (Kg)
Table 37. Asia Pacific Gastroparesis Drugs Sales by Region (2026-2031) & (Kg)
Table 38. Asia Pacific Gastroparesis Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Gastroparesis Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gastroparesis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
Table 42. Latin America Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
Table 43. Latin America Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Gastroparesis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
Table 47. Middle East and Africa Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
Table 48. Middle East and Africa Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Gastroparesis Drugs Sales (Kg) by Type (2020-2025)
Table 51. Global Gastroparesis Drugs Sales (Kg) by Type (2026-2031)
Table 52. Global Gastroparesis Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Gastroparesis Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Gastroparesis Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Gastroparesis Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Gastroparesis Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Gastroparesis Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Gastroparesis Drugs Price (US$/mg) by Type (2020-2025)
Table 59. Global Gastroparesis Drugs Price (US$/mg) by Type (2026-2031)
Table 60. Global Gastroparesis Drugs Sales (Kg) by Application (2020-2025)
Table 61. Global Gastroparesis Drugs Sales (Kg) by Application (2026-2031)
Table 62. Global Gastroparesis Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Gastroparesis Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Gastroparesis Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Gastroparesis Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Gastroparesis Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Gastroparesis Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Gastroparesis Drugs Price (US$/mg) by Application (2020-2025)
Table 69. Global Gastroparesis Drugs Price (US$/mg) by Application (2026-2031)
Table 70. Sumitomo Company Information
Table 71. Sumitomo Description and Business Overview
Table 72. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 73. Sumitomo Gastroparesis Drugs Product
Table 74. Sumitomo Recent Developments/Updates
Table 75. Cadila Pharmaceuticals Company Information
Table 76. Cadila Pharmaceuticals Description and Business Overview
Table 77. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 78. Cadila Pharmaceuticals Gastroparesis Drugs Product
Table 79. Cadila Pharmaceuticals Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 83. Sanofi Gastroparesis Drugs Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Teva Company Information
Table 86. Teva Description and Business Overview
Table 87. Teva Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 88. Teva Gastroparesis Drugs Product
Table 89. Teva Recent Developments/Updates
Table 90. Johnson & Johnson Company Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 93. Johnson & Johnson Gastroparesis Drugs Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 98. Pfizer Gastroparesis Drugs Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Kyowa Kirin Pharmaceuticals Company Information
Table 101. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 102. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 103. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product
Table 104. Kyowa Kirin Pharmaceuticals Recent Developments/Updates
Table 105. Hanmi Pharm Company Information
Table 106. Hanmi Pharm Description and Business Overview
Table 107. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 108. Hanmi Pharm Gastroparesis Drugs Product
Table 109. Hanmi Pharm Recent Developments/Updates
Table 110. Ani Pharmaceuticals Company Information
Table 111. Ani Pharmaceuticals Description and Business Overview
Table 112. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 113. Ani Pharmaceuticals Gastroparesis Drugs Product
Table 114. Ani Pharmaceuticals Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Gastroparesis Drugs Distributors List
Table 118. Gastroparesis Drugs Customers List
Table 119. Gastroparesis Drugs Market Trends
Table 120. Gastroparesis Drugs Market Drivers
Table 121. Gastroparesis Drugs Market Challenges
Table 122. Gastroparesis Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gastroparesis Drugs
Figure 2. Global Gastroparesis Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gastroparesis Drugs Market Share by Type: 2024 & 2031
Figure 4. Prokinetic Agents Product Picture
Figure 5. Antiemetic Agents Product Picture
Figure 6. Others Product Picture
Figure 7. Global Gastroparesis Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Gastroparesis Drugs Market Share by Application: 2024 & 2031
Figure 9. Diabetic Gastroparesis
Figure 10. Idiopathic Gastroparesis
Figure 11. Global Gastroparesis Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gastroparesis Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Gastroparesis Drugs Sales (2020-2031) & (Kg)
Figure 14. Global Gastroparesis Drugs Average Price (US$/mg) & (2020-2031)
Figure 15. Gastroparesis Drugs Report Years Considered
Figure 16. Gastroparesis Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Gastroparesis Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Gastroparesis Drugs Players: Market Share by Revenue in Gastroparesis Drugs in 2024
Figure 19. Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Gastroparesis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Gastroparesis Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Gastroparesis Drugs Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Gastroparesis Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Gastroparesis Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Gastroparesis Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Gastroparesis Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Gastroparesis Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Gastroparesis Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Gastroparesis Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Gastroparesis Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Gastroparesis Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Gastroparesis Drugs by Type (2020-2031)
Figure 55. Global Gastroparesis Drugs Price (US$/mg) by Type (2020-2031)
Figure 56. Global Sales Market Share of Gastroparesis Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Gastroparesis Drugs by Application (2020-2031)
Figure 58. Global Gastroparesis Drugs Price (US$/mg) by Application (2020-2031)
Figure 59. Gastroparesis Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Gastroparesis Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Gastroparesis Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Gastroparesis Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Gastroparesis Drugs Sales (Kg) of Key Manufacturers (2020-2025)
Table 5. Global Gastroparesis Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Gastroparesis Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Gastroparesis Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Gastroparesis Drugs Average Price (US$/mg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Gastroparesis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gastroparesis Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gastroparesis Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Gastroparesis Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gastroparesis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroparesis Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gastroparesis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Gastroparesis Drugs Sales by Region (2020-2025) & (Kg)
Table 18. Global Gastroparesis Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Gastroparesis Drugs Sales by Region (2026-2031) & (Kg)
Table 20. Global Gastroparesis Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Gastroparesis Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Gastroparesis Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Gastroparesis Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Gastroparesis Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Gastroparesis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
Table 27. North America Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
Table 28. North America Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Gastroparesis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
Table 32. Europe Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
Table 33. Europe Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Gastroparesis Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Gastroparesis Drugs Sales by Region (2020-2025) & (Kg)
Table 37. Asia Pacific Gastroparesis Drugs Sales by Region (2026-2031) & (Kg)
Table 38. Asia Pacific Gastroparesis Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Gastroparesis Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gastroparesis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
Table 42. Latin America Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
Table 43. Latin America Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Gastroparesis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Gastroparesis Drugs Sales by Country (2020-2025) & (Kg)
Table 47. Middle East and Africa Gastroparesis Drugs Sales by Country (2026-2031) & (Kg)
Table 48. Middle East and Africa Gastroparesis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Gastroparesis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Gastroparesis Drugs Sales (Kg) by Type (2020-2025)
Table 51. Global Gastroparesis Drugs Sales (Kg) by Type (2026-2031)
Table 52. Global Gastroparesis Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Gastroparesis Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Gastroparesis Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Gastroparesis Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Gastroparesis Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Gastroparesis Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Gastroparesis Drugs Price (US$/mg) by Type (2020-2025)
Table 59. Global Gastroparesis Drugs Price (US$/mg) by Type (2026-2031)
Table 60. Global Gastroparesis Drugs Sales (Kg) by Application (2020-2025)
Table 61. Global Gastroparesis Drugs Sales (Kg) by Application (2026-2031)
Table 62. Global Gastroparesis Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Gastroparesis Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Gastroparesis Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Gastroparesis Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Gastroparesis Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Gastroparesis Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Gastroparesis Drugs Price (US$/mg) by Application (2020-2025)
Table 69. Global Gastroparesis Drugs Price (US$/mg) by Application (2026-2031)
Table 70. Sumitomo Company Information
Table 71. Sumitomo Description and Business Overview
Table 72. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 73. Sumitomo Gastroparesis Drugs Product
Table 74. Sumitomo Recent Developments/Updates
Table 75. Cadila Pharmaceuticals Company Information
Table 76. Cadila Pharmaceuticals Description and Business Overview
Table 77. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 78. Cadila Pharmaceuticals Gastroparesis Drugs Product
Table 79. Cadila Pharmaceuticals Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 83. Sanofi Gastroparesis Drugs Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Teva Company Information
Table 86. Teva Description and Business Overview
Table 87. Teva Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 88. Teva Gastroparesis Drugs Product
Table 89. Teva Recent Developments/Updates
Table 90. Johnson & Johnson Company Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 93. Johnson & Johnson Gastroparesis Drugs Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 98. Pfizer Gastroparesis Drugs Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Kyowa Kirin Pharmaceuticals Company Information
Table 101. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 102. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 103. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product
Table 104. Kyowa Kirin Pharmaceuticals Recent Developments/Updates
Table 105. Hanmi Pharm Company Information
Table 106. Hanmi Pharm Description and Business Overview
Table 107. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 108. Hanmi Pharm Gastroparesis Drugs Product
Table 109. Hanmi Pharm Recent Developments/Updates
Table 110. Ani Pharmaceuticals Company Information
Table 111. Ani Pharmaceuticals Description and Business Overview
Table 112. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 113. Ani Pharmaceuticals Gastroparesis Drugs Product
Table 114. Ani Pharmaceuticals Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Gastroparesis Drugs Distributors List
Table 118. Gastroparesis Drugs Customers List
Table 119. Gastroparesis Drugs Market Trends
Table 120. Gastroparesis Drugs Market Drivers
Table 121. Gastroparesis Drugs Market Challenges
Table 122. Gastroparesis Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gastroparesis Drugs
Figure 2. Global Gastroparesis Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gastroparesis Drugs Market Share by Type: 2024 & 2031
Figure 4. Prokinetic Agents Product Picture
Figure 5. Antiemetic Agents Product Picture
Figure 6. Others Product Picture
Figure 7. Global Gastroparesis Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Gastroparesis Drugs Market Share by Application: 2024 & 2031
Figure 9. Diabetic Gastroparesis
Figure 10. Idiopathic Gastroparesis
Figure 11. Global Gastroparesis Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gastroparesis Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Gastroparesis Drugs Sales (2020-2031) & (Kg)
Figure 14. Global Gastroparesis Drugs Average Price (US$/mg) & (2020-2031)
Figure 15. Gastroparesis Drugs Report Years Considered
Figure 16. Gastroparesis Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Gastroparesis Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Gastroparesis Drugs Players: Market Share by Revenue in Gastroparesis Drugs in 2024
Figure 19. Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Gastroparesis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Gastroparesis Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Gastroparesis Drugs Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Gastroparesis Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Gastroparesis Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Gastroparesis Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Gastroparesis Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Gastroparesis Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Gastroparesis Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Gastroparesis Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Gastroparesis Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Gastroparesis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Gastroparesis Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Gastroparesis Drugs by Type (2020-2031)
Figure 55. Global Gastroparesis Drugs Price (US$/mg) by Type (2020-2031)
Figure 56. Global Sales Market Share of Gastroparesis Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Gastroparesis Drugs by Application (2020-2031)
Figure 58. Global Gastroparesis Drugs Price (US$/mg) by Application (2020-2031)
Figure 59. Gastroparesis Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232